Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine

Vaccine

Volumn 29, Issue 49, 2011, Pages 9194-9200

  Rosella, Laura C ^a,b   Groenwold, Rolf H H ^c   Crowcroft, Natasha S ^a,b,d  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Confounding; Influenza; Influenza vaccine; Pandemic H1N1

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CONFOUNDING VARIABLE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; SCHOOL CHILD; SEASONAL INFLUENZA; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; ONTARIO; PANDEMICS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 82555169551     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.132     Document Type: Article

References (40)

1. Skowronski D.M., De Serres G., Crowcroft N.S., Janjua N.Z., Boulianne N., Hottes T.S. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring/Summer 2009: four observational studies from Canada. PLoS Medicine 2010, 7(April (4)):e1000258.
2. Jackson L.A., Jackson M.L., Nelson J.C., Neuzil K.M., Weiss N.S. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. International Journal of Epidemiology 2006, 35(2):337-344.
3. Nichol K.L., Wuorenma J., von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine 1998, 158(16):1769-1776.
4. Simonsen L. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infectious Diseases 2007, 7(10):658-666.
5. Simonsen L. Mortality benefits of influenza vaccination in elderly people. Reply. Lancet Infectious Diseases 2008, 8(8):463-465.
6. Rosenbaum P.R. The central role of the propensity score in observational studies for causal effects. Journal of the American Statistical Association 1984, 79(387):516-524.
7. Rosenbaum P.R. Reducing bias in observational studies using subclassification on the propensity score. Biometrika 1983, 70(1):41-55.
8. Austin P.C. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. Journal of Thoracic and Cardiovascular Surgery 2007, 134(5):1128-1135.
9. Austin P.C. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Statistics in Medicine 2007, 26(4):734-753.
10. Parson L. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference 2001, SAS Institute Inc, Cary, NC, p. 214-216.
11. Groenwold R.H.H., Nelson D.B., Nichol K.L., Hoes A.W., Hak E. Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research. International Journal of Epidemiology 2010, 39(1):107-117.
12. Greenland S. Basic methods for sensitivity analysis of biases. International Journal of Epidemiology 1996, 25(6):1107-1116.
13. Rubin D.B. Multiple inputation for nonresponse in surveys 1987, John Wiley and Sons, Hoboken, New Jersey. 1st ed.
14. Statistics Canada Canadian Community Health Survey methodological overview. Health Reports 2002, 13:9-14.
15. Statistics Canada Canadian Community Health Survey 2000-2001 2003, Statistics Canada, Ottawa.
16. Statistics Canada. Table 105-0501 - health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions and peer groups, occasional. CANSIM (database); 2011. [accessed September 22, 2011]. http://www5.statcan.gc.ca/cansim/a01%3Flang=eng.
17. Baxter R., Lee J., Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. Journal of Infectious Diseases 2010, 201(2):186-189.
18. Groenwold R.H.H., Hoes A.W., Nichol K.L., Hak E. Quantifying the potential role of unmeasured confounders: the example of influenza vaccination. International Journal of Epidemiology 2008, 37(6):1422-1429.
19. Hak E., Verheij T.J.M., Grobbee D.E., Nichol K.L., Hoes A.W. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. Journal of Epidemiology and Community Health 2002, 56(12):951-955.
20. Brookhart M.A., Patrick A.R., Dormuth C., Avorn J., Shrank W., Cadarette S.M., et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. American Journal of Epidemiology 2007, 166(3):348-354.
21. Eurich D.T., Marrie T.J., Johnstone J., Majumdar S.R. Mortality reduction with influenza vaccine in patients with pneumonia outside " Flu" season - pleiotropic benefits or residual confounding?. American Journal of Respiratory and Critical Care Medicine 2008, 178(5):527-533.
22. Epidemiological summary of pandemic influenza A (H1N1) 2009 virus - Ontario, Canada, June 2009. Weekly Epidemiological Record (WER) 47[84]. World Health Organization; 20-11-2009. p. 485-92.
23. Crum-Cianflone N.F., Blair P.J., Faix D., Arnold J., Echols S., Sherman S.S., et al. Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States Military beneficiaries. Clinical Infectious Diseases 2009, 49(12):1801-1810.
24. Janjua N.Z., Skowronski D.M., Hottes T.S., Osei W., Adams E., Petric M., et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clinical Infectious Diseases 2010, 51(9):1017-1027.
25. Carcione D., Giele C., Goggin L.S., Kwan K.S., Smith D.W., Dowse G.K., et al. Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. Eurosurveillance 2010, 15(28):2-4.
26. Gargiullo P., Shay D.K., Katz J., Bramley A., Nowell M., Michalove J., et al. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. MMWR Morbidity and Mortality Weekly Report 2009, 58(November (44)):1241-1245.
27. Kelly H., Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Eurosurveillance 2009, 14(31):6-10.
28. Garcia-Garcia L., Valdespino-Gomez J.L., Lazcano-Ponce E., Jimenez-Corona A., Higuera-Iglesias A., Cruz-Hervert P., et al. Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009 case-control study in Mexico City. British Medical Journal 2009, 339.
29. Johns M.C., Eick A.A., Blazes D.L., Lee S.E., Perdue C.L., Lipnick R., et al. Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US Military personnel. PLoS One 2010, 5(5.).
30. Irving S.A., Donahue J.G., Shay D.K., Ellis-Coyle T.L., Belongia E.A. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009, 27(47):6546-6549.
31. Mangtani P., Shah A., Roberts J.A. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiology and Infection 2007, 135(1):139-143.
32. Zimmerman R.K, Raymund M., Janosky J.E., Nowalk M.P., Fine M.J. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003, 21(13-14):1486-1491.
33. Mac Donald R., Baken L., Nelson A., Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. American Journal of Preventive Medicine 1999, 16(3):173-177.
34. Ontario Ministry of Health and Long Term Care. The H1N1 pandemic - how Ontario fared: a report by Ontario's Chief Medical Officer of Health. Toronto, Ontario: Queen's Printer for Ontario; 2010.
35. Orenstein E.W., De Serres G., Haber A.J., Shay D.K., Bridges C.B., Gargiullo P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007, 36(3):623-631.
36. Skowronski D.M. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007, 25(15):2842-2851.
37. Skowronski D.M. Component-specific effectiveness of trivalent influenza vaccine as monitored through a Sentinel Surveillance Network in Canada, 2006-2007. Journal of Infectious Diseases 2009, 199(2):168-179.
38. Fewell Z., Smith G.D., Sterne J.A.C. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. American Journal of Epidemiology 2007, 166(6):646-655.
39. Steenland K., Greenland S. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. American Journal of Epidemiology 2004, 160(4):384-392.
40. McCandless L.C., Gustafson P., Levy A.R. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding. Journal of Clinical Epidemiology 2008, 61(3):247-255.